Tobacco use drives large health and fiscal costs for Medicaid, yet few enrollees who use these products receive cessation pharmacotherapy. We estimated that 10. 4 percent of daily tobacco or nicotine users received cessation medications in 2024, and Medicaid programs spent 137. 6 million on such treatments that year. State-level treatment rates ranged from 1. 3 percent to 26. 6 percent.
Clemans-Cope et al. (Mon,) studied this question.